Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Semen Analysis Market: By Product Type, By Sample Source, By Application, By End User, and Geography
Semen Analysis Market: By Product Type, By Sample Source, By Application, By End User, and Geography
Semen Analysis market size was valued at US$ 350.0 million in 2023 and is poised to grow at a significant CAGR of 8.0% over 2024-2030. Male factor infertility constitutes the majority of the increase in infertility cases and is an essential driver of the semen analysis industry. According to WHO multicenter studies, a substantial percentage of infertility is linked to the male partner's reproductive abnormalities or illnesses. Also, one out of every four couples in developing nations has infertility, and it has been estimated that more than 50 million people have infertility. There is an increasing demand for semen analysis, which helps to determine the health, quality, and viability of sperm. In addition, the test will reveal if infertility is caused by a low sperm count or sperm malfunction. Furthermore, the availability of technologically advanced product offerings will create further prospects for the semen analysis market to flourish in the future years.
Microscopy, chromatographic immunoassay, colorimetric reaction, and smartphone-based testing have all helped the healthcare business fulfill the needs of the new generation of patients. The demand for assisted reproductive technologies (ARTs) has altered growth dynamics beneficially. In the semen analysis market, manufacturers are focused on enhancing the accuracy of sperm quality assessment, which helps to address patients' evolving needs. The prospects have been enhanced by a growing grasp of specimen needs and procedures. The availability of improved smartphone-enabled testing in industrialized countries has boosted the market growth. The value chain of stakeholders has been enriched by the increasing number of fertility clinics in developed and developing economies. The rise in funding and supportive government initiatives across various countries is anticipated to boost the adoption of fertility treatments. The Singapore government offers around 75% co-funding for different Assisted Reproductive Technology (ART) procedures, such as IVF, Gamete Intrafallopian Transfer (GIFT), and Intracytoplasmic Sperm Injection (ICSI).
In July 2021, Halotech participated in the catalogue of ANACER - National Association of Assisted Reproduction Clinics – highlighting the importance of the DNA fragmentation test.
Study Period
2024-2030Base Year
2023CAGR
8%Largest Market
EuropeFastest Growing Market
North America
Cigarette smoking, alcohol usage, illicit drug use, obesity, psychological stress, and caffeine intake are all factors that can affect sperm quality. This is expected to increase the global market's growth in the coming years. The market is expected to be driven by increased awareness of advanced fertility methods such as IUI and IVF, increased spending capacity, and high adoption of advanced semen analysis methods such as computer-assisted semen analysis (CASA) by diagnostic laboratories. Furthermore, the worldwide semen analysis market is expected to be propelled by an increase in the number of companion animals, a jump in demand for animal food, and an increase in animal research facilities. The global semen analysis market is expected to be restrained by the high cost of assisted reproductive technologies, low awareness in economically underdeveloped nations, and strict tax restrictions on medical devices in the United States.
The Semen Analysis Market in North America is likely to hold a revenue share of 30% in 2022, and, in the following years, it is predicted to increase rapidly. The rise in male infertility and the availability of sophisticated fertility treatments are boosting the semen analysis market in the North American region. Due to an increase in the infertility rate, Europe held a significant share of the global semen analysis market. According to the United Nations Population Fund (UNFPA), Southern Europe, Eastern Europe, and Eastern Asia have the lowest fertility rates globally, with an average of 1.5 children per woman in 2018. Due to the high cost of IVF treatment in Europe and the United States, the market in the Asia Pacific is predicted to grow at a high CAGR during the forecast period, owing to a fast-increasing rate of infertility, expanding export of animal products, and an increase in fertility tourism. This is projected to boost the Asia Pacific semen analysis market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 350.0 million |
|
Market CAGR |
8% |
|
By Product Type |
|
|
By Sample Source |
|
|
By Application |
|
|
By End User |
|
Download Free Sample Report
The global semen analysis market size was valued at US$ 350.0 million in 2023 and is projected to grow at a CAGR of 8.0% from 2024 to 2030.
Akymed, Hamilton Thorne Inc, Microptic S.L., MotilityCount Aps, ContraVac Inc.
North America is the fastest-growing region for semen analysis market
17. Key Assumptions and Acronyms
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.